CANVAS: Straight Talk Needed on Amputation Risk CANVAS: Straight Talk Needed on Amputation Risk

Can a meta-analysis of two different studies or data from observational studies overcome the clinical concern about the clear-cut amputation risk with canagliflozin seen in the CANVAS trial?Medscape Diabetes & Endocrinology
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Diabetes & Endocrinology Expert Column Source Type: news